Anbio Biotechnology Class A Ordinary Shares (NNNN) — Capital Reinvestment Ratio
Anbio Biotechnology Class A Ordinary Shares (NNNN) has a Capital Reinvestment Ratio of 0.00x as of December 2024, meaning it reinvests 0% of its operating cash flow ($1.60 Million) in capital expenditures ($1.67). Check Anbio Biotechnology Class A Ordinary Sha (NNNN) tangible net worth to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Anbio Biotechnology Class A Ordinary Shares Capital Reinvestment Ratio (2022–2022)
This chart tracks Anbio Biotechnology Class A Ordinary Shares's Capital Reinvestment Ratio across 1 annual periods. For the full cash flow conversion analysis, see NNNN operating cash flow.
Annual Capital Reinvestment Ratio for Anbio Biotechnology Class A Ordinary Shares (2022–2022)
Year-by-year Capital Reinvestment Ratio for Anbio Biotechnology Class A Ordinary Shares from 2022 to 2022. See Anbio Biotechnology Class A Ordinary Sha (NNNN) FCF generation index to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2022 | 0.00x | $4.45 Million | $2.88 | — |